349 related articles for article (PubMed ID: 12209516)
1. Identification of synovium-specific homing peptides by in vivo phage display selection.
Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.
Kamperidis P; Kamalati T; Ferrari M; Jones M; Garrood T; Smith MD; Diez-Posada S; Hughes C; Finucane C; Mather S; Nissim A; George AJ; Pitzalis C
Arthritis Rheum; 2011 Dec; 63(12):3758-67. PubMed ID: 21953304
[TBL] [Abstract][Full Text] [Related]
3. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
4. Identification of peptide sequences that target to the brain using in vivo phage display.
Li J; Zhang Q; Pang Z; Wang Y; Liu Q; Guo L; Jiang X
Amino Acids; 2012 Jun; 42(6):2373-81. PubMed ID: 21792566
[TBL] [Abstract][Full Text] [Related]
5. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells.
Nowakowski GS; Dooner MS; Valinski HM; Mihaliak AM; Quesenberry PJ; Becker PS
Stem Cells; 2004; 22(6):1030-8. PubMed ID: 15536193
[TBL] [Abstract][Full Text] [Related]
6. Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display.
Schluesener HJ; Xianglin T
J Neurol Sci; 2004 Sep; 224(1-2):77-82. PubMed ID: 15450774
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
[TBL] [Abstract][Full Text] [Related]
8. Identification of polypeptides with selective affinity to intact mouse cerebellar granule neurons from a random peptide-presenting phage library.
Hou ST; Dove M; Anderson E; Zhang J; MacKenzie CR
J Neurosci Methods; 2004 Sep; 138(1-2):39-44. PubMed ID: 15325109
[TBL] [Abstract][Full Text] [Related]
9. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer].
Wang Y; Wu KC; Nie YZ; Han ZY; Han QL; Qiao TD; Fan DM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):469-72. PubMed ID: 15169660
[TBL] [Abstract][Full Text] [Related]
10. In vivo phage display selection in the human/SCID mouse chimera model for defining synovial specific determinants.
Lee L; Garrood T; Pitzalis C
Methods Mol Med; 2007; 136():369-94. PubMed ID: 17983161
[TBL] [Abstract][Full Text] [Related]
11. Identification of nose-to-brain homing peptide through phage display.
Wan XM; Chen YP; Xu WR; Yang WJ; Wen LP
Peptides; 2009 Feb; 30(2):343-50. PubMed ID: 19007831
[TBL] [Abstract][Full Text] [Related]
12. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
[TBL] [Abstract][Full Text] [Related]
13. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
14. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
15. [Selection of the peptides specifically binding to hepatoma by using phage display in vivo].
Du B; Yu J; Zhou ZL; Zhang P; Yu M; Qian M
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):645-7. PubMed ID: 16438882
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling.
Ballard VL; Holm JM; Edelberg JM
Physiol Genomics; 2006 Aug; 26(3):202-8. PubMed ID: 16705020
[TBL] [Abstract][Full Text] [Related]
17. Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.
Yang Yu ; Zizheng Wang ; Tongxin Du
J Biomol Screen; 2008 Dec; 13(10):968-74. PubMed ID: 18978306
[TBL] [Abstract][Full Text] [Related]
18. Organ targeting in vivo using phage display peptide libraries.
Pasqualini R; Ruoslahti E
Nature; 1996 Mar; 380(6572):364-6. PubMed ID: 8598934
[TBL] [Abstract][Full Text] [Related]
19. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
20. Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier.
Hamzeh-Mivehroud M; Mahmoudpour A; Rezazadeh H; Dastmalchi S
Eur J Pharm Biopharm; 2008 Oct; 70(2):577-81. PubMed ID: 18602466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
